|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
103,450,000 |
Market
Cap: |
2.06(M) |
Last
Volume: |
1,573,194 |
Avg
Vol: |
1,568,804 |
52
Week Range: |
$0.0199 - $0.0199 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Machek James Edward |
VP-Research & Development |
|
2016-05-23 |
4 |
D |
$0.00 |
$0 |
D/D |
(761) |
45,743 |
|
- |
|
Machek James Edward |
VP-Research & Development |
|
2016-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
2,023 |
46,504 |
|
- |
|
Lima Jose A. |
VP-Quality |
|
2016-05-23 |
4 |
D |
$0.00 |
$0 |
D/D |
(333) |
38,841 |
|
- |
|
Lima Jose A. |
VP-Quality |
|
2016-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
885 |
39,174 |
|
- |
|
Mcdermott John D |
Chief Executive Officer |
|
2016-05-23 |
4 |
D |
$0.00 |
$0 |
D/D |
(6,652) |
663,624 |
|
- |
|
Mcdermott John D |
Chief Executive Officer |
|
2016-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
17,699 |
670,276 |
|
- |
|
Chavez Christopher G |
Director |
|
2016-04-25 |
4/A |
A |
$0.00 |
$0 |
D/D |
328,586 |
355,540 |
|
- |
|
Chavez Christopher G |
Director |
|
2016-02-29 |
4 |
A |
$0.00 |
$0 |
I/I |
131,280 |
65,640 |
|
- |
|
Chavez Christopher G |
Director |
|
2016-02-29 |
4 |
A |
$0.00 |
$0 |
D/D |
285,280 |
312,234 |
|
- |
|
Oquinn Shari L |
VP, Clinical & Regulatory |
|
2016-02-29 |
4 |
S |
$0.00 |
$0 |
D/D |
(4,000) |
54,522 |
|
- |
|
Oquinn Shari L |
VP, Clinical & Regulatory |
|
2016-02-29 |
4 |
A |
$0.00 |
$0 |
D/D |
18,681 |
58,522 |
|
- |
|
Chobotov Michael V. |
Chief Technology Officer |
|
2016-02-29 |
4 |
A |
$0.00 |
$0 |
D/D |
116,948 |
203,269 |
|
- |
|
Mcdermott John D |
Chief Executive Officer |
|
2016-02-04 |
4 |
A |
$0.00 |
$0 |
D/D |
106,242 |
667,506 |
|
- |
|
Machek James Edward |
VP-Research & Development |
|
2016-02-04 |
4 |
A |
$0.00 |
$0 |
D/D |
13,280 |
46,504 |
|
- |
|
Ferracci Cecile |
General Manager, Europe |
|
2016-02-04 |
4 |
A |
$0.00 |
$0 |
D/D |
11,952 |
40,706 |
|
- |
|
Mahboob Vaseem |
Chief Financial Officer |
|
2016-02-04 |
4 |
A |
$0.00 |
$0 |
D/D |
33,201 |
88,511 |
|
- |
|
Depalma Amanda L. |
VP, Global Marketing |
|
2016-02-04 |
4 |
A |
$0.00 |
$0 |
D/D |
14,608 |
43,423 |
|
- |
|
Jennings David M. |
VP-Human Resources |
|
2016-02-04 |
4 |
A |
$0.00 |
$0 |
D/D |
12,616 |
49,681 |
|
- |
|
Mitchell Robert D |
President |
|
2016-02-04 |
4 |
A |
$0.00 |
$0 |
D/D |
33,201 |
315,462 |
|
- |
|
Lima Jose A. |
VP-Quality |
|
2016-02-04 |
4 |
A |
$0.00 |
$0 |
D/D |
11,952 |
38,240 |
|
- |
|
Dejohn Joseph A. |
VP- Global Sales |
|
2016-02-04 |
4 |
A |
$0.00 |
$0 |
D/D |
11,952 |
158,627 |
|
- |
|
Oquinn Shari L |
VP, Clinical & Regulatory |
|
2016-02-04 |
4 |
A |
$0.00 |
$0 |
D/D |
39,841 |
39,841 |
|
- |
|
Chobotov Michael V. |
Chief Technology Officer |
|
2016-02-04 |
4 |
A |
$0.00 |
$0 |
D/D |
86,321 |
86,321 |
|
- |
|
Chobotov Michael V. |
Chief Technology Officer |
|
2016-02-03 |
4/A |
A |
$7.42 |
$867,754 |
D/D |
116,948 |
203,269 |
|
- |
|
Chavez Christopher G |
Director |
|
2016-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
26,954 |
26,954 |
|
- |
|
709 Records found
|
|
Page 8 of 29 |
|
|